Over-the-counter heartburn drug Zantac pulled in US, Canada

Business News

FILE – This Sept. 30, 2019, file photo shows a box of Maximum Strength Zantac tablets at a pharmacy in Miami Beach, Fla. Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination. The French company Friday, Oct. 18, 2019 joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug. (AP Photo/Wilfredo Lee, File)

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.

Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination.

The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug.

In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor.

Several drugstore chains have already removed Zantac and generic versions from store shelves.

Copyright 2020 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

COVID-19 IN CENTRAL ILLINOIS

National Unemployment Tracker

Trending Stories

Latest Local News

More Local News